Cargando…
Effect of Adenine Arabinoside and α-Interferon in Patients with HBeAg-positive Chronic Active Hepatitis
To evaluate and compare the therapeutic efficacy of adenine arabinoside (Ara-A) and alpha-interferon (α-INF), 40 patients with biopsy proven chronic active hepatitis B were chosen at random to receive Ara-A (15 mg/Kg, iv, for 10 day) or α-INF (3 million unit, sc, every other day for 12 wks) and foll...
Autores principales: | Lee, Sang Uk, Choi, Kyung Hee, Ha, Bong Jun, Suh, Sung Yun, Han, Byung Hoon, Ku, Ja Young, Park, Byung Chae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association of Internal Medicine
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535000/ https://www.ncbi.nlm.nih.gov/pubmed/2271507 http://dx.doi.org/10.3904/kjim.1990.5.1.1 |
Ejemplares similares
-
Correlations of HBV Genotypes, Mutations Affecting HBeAg Expression and HBeAg/ anti-HBe Status in HBV Carriers
por: Lim, Chee Kent, et al.
Publicado: (2006) -
HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patients
por: Yang, Song, et al.
Publicado: (2016) -
Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?
por: Song, Byung-Cheol, et al.
Publicado: (2014) -
Is the function of the HBeAg really unknown?
por: Milich, David R.
Publicado: (2019) -
Differential Plasma MicroRNA Profiles in HBeAg Positive and HBeAg Negative Children with Chronic Hepatitis B
por: Winther, Thilde Nordmann, et al.
Publicado: (2013)